0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Oncology Based In Vitro CRO Market: Accelerating Cancer Drug Development with Specialized Research ServicesThe global fight against cancer demands continuous innovation in drug discovery and development, a process that is increasingly reliant on specialized external expertise. At the center of this ecosystem is the Oncology Based In Vitro CRO Market . Oncology-based in vitro Contract Research Organizations (CROs) provide essential laboratory and research services to pharmaceutical,...0 Commentaires 0 Parts 231 Vue 0 Aperçu
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Circular RNA Therapeutics Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Cytotoxic Drugs Market Size, Share, Trends & Forecast to 2032According to the latest report published by Data Bridge Market Research, the Cytotoxic Drugs Market Global cytotoxic drugs market size was valued at USD 17.59 billion in 2024 and is projected to reach USD 42.11 billion by 2032, with a CAGR of 7.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate,...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Global Thalidomide Market Develops With Expanding Therapeutic Applications and Pharmaceutical ResearchAccording to the latest report published by Data Bridge Market Research, the Thalidomide Market CAGR Value The global Thalidomide market size was valued at USD 1.71 billion in 2025 and is expected to reach USD 2.89 billion by 2033, at a CAGR of 6.80% during the forecast period This Thalidomide Market research report is generated with a nice blend...0 Commentaires 0 Parts 374 Vue 0 Aperçu
-
Ovarian Cancer Drugs Market: Developments in Cancer Drug ResearchThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Commentaires 0 Parts 868 Vue 0 Aperçu
-
Uterine Carcinosarcoma Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market The Uterine Carcinosarcoma Market was valued at USD 25.72 billion in 2025 and is projected to reach USD 42.56 billion by 2033, growing at a CAGR of 6.50% from 2026 to 2033. The market is witnessing steady growth driven by increasing incidence of rare and...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali